Reverse Genetics of Measles Virus and Resulting Multivalent Recombinant Vaccines: Applications of Recombinant Measles Viruses

[1]  R. Cattaneo,et al.  Attenuation of V- or C-Defective Measles Viruses: Infection Control by the Inflammatory and Interferon Responses of Rhesus Monkeys , 2008, Journal of Virology.

[2]  F. Tangy,et al.  Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines. , 2008, Comparative immunology, microbiology and infectious diseases.

[3]  D. Kelvin,et al.  Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses , 2008, Vaccine.

[4]  P. Desprès,et al.  Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus , 2007, PLoS neglected tropical diseases.

[5]  R. Cattaneo,et al.  Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine. , 2007, Cancer research.

[6]  R. Cattaneo,et al.  An immunocompetent murine model for oncolysis with an armed and targeted measles virus. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Qingzhong Yu,et al.  Evaluation of Newcastle disease virus chimeras expressing the Hemagglutinin-Neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone. , 2007, Virus research.

[8]  R. M. Hendry,et al.  Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in Mice , 2007, Journal of Virology.

[9]  A. García-Sastre,et al.  Rescue of influenza A virus from recombinant DNA. , 2007, Journal of virology.

[10]  A. Arnold,et al.  Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy , 2007, Gene Therapy.

[11]  G. Kobinger,et al.  Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection. , 2007, Virology.

[12]  A. García-Sastre,et al.  Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. , 2007, Cancer research.

[13]  R. Cattaneo,et al.  A Vectored Measles Virus Induces Hepatitis B Surface Antigen Antibodies While Protecting Macaques against Measles Virus Challenge , 2007, Journal of Virology.

[14]  P. Whitaker-Dowling,et al.  Treatment of implanted mammary tumors with recombinant vesicular stomatitis virus targeted to Her2/neu , 2007, International journal of cancer.

[15]  N. Hayashi,et al.  Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins , 2007, Journal of Virology.

[16]  B. Murphy,et al.  Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens , 2007, Proceedings of the National Academy of Sciences.

[17]  D. Zelterman,et al.  Vesicular Stomatitis Virus-Based Therapeutic Vaccination Targeted to the E1, E2, E6, and E7 Proteins of Cottontail Rabbit Papillomavirus , 2007, Journal of Virology.

[18]  R. Vile,et al.  Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus. , 2007, Cancer research.

[19]  M. Roberts,et al.  Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus. , 2007, Current cancer drug targets.

[20]  M. Billeter,et al.  Attenuated measles virus as a vaccine vector , 2007, Vaccine.

[21]  J. Rose,et al.  An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge. , 2007, Vaccine.

[22]  J. Rose,et al.  Replication and Propagation of Attenuated Vesicular Stomatitis Virus Vectors In Vivo: Vector Spread Correlates with Induction of Immune Responses and Persistence of Genomic RNA , 2006, Journal of Virology.

[23]  R. M. Hendry,et al.  Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates , 2006, Virology.

[24]  Hualan Chen,et al.  Newcastle Disease Virus-Based Live Attenuated Vaccine Completely Protects Chickens and Mice from Lethal Challenge of Homologous and Heterologous H5N1 Avian Influenza Viruses , 2006, Journal of Virology.

[25]  R. M. Hendry,et al.  Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector , 2006, Springer Seminars in Immunopathology.

[26]  T. Monath,et al.  Viral vectors for malaria vaccine development , 2006, Vaccine.

[27]  R. Cattaneo,et al.  Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases. , 2006, Cancer research.

[28]  P. Staeheli,et al.  RNA Polymerase II-Controlled Expression of Antigenomic RNA Enhances the Rescue Efficacies of Two Different Members of the Mononegavirales Independently of the Site of Viral Genome Replication , 2006, Journal of Virology.

[29]  M. Takeda,et al.  Generation of Measles Virus with a Segmented RNA Genome , 2006, Journal of Virology.

[30]  M. Takeda,et al.  Long Untranslated Regions of the Measles Virus M and F Genes Control Virus Replication and Cytopathogenicity , 2005, Journal of Virology.

[31]  F. Tangy,et al.  Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector. , 2005, Viral immunology.

[32]  P. Desprès,et al.  Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. , 2005, The Journal of infectious diseases.

[33]  T. Monath,et al.  ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and Efficacy , 2004, Journal of Virology.

[34]  L. Mollet,et al.  A Single Injection of Recombinant Measles Virus Vaccines Expressing Human Immunodeficiency Virus (HIV) Type 1 Clade B Envelope Glycoproteins Induces Neutralizing Antibodies and Cellular Immune Responses to HIV , 2004, Journal of Virology.

[35]  M. Billeter,et al.  Vaccination of rhesus macaques with a recombinant measles virus expressing interleukin-12 alters humoral and cellular immune responses. , 2003, The Journal of infectious diseases.

[36]  L. Mollet,et al.  A Molecularly Cloned Schwarz Strain of Measles Virus Vaccine Induces Strong Immune Responses in Macaques and Transgenic Mice , 2003, Journal of Virology.

[37]  F. Guirakhoo,et al.  Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. , 2003, The Journal of infectious diseases.

[38]  M. St. Claire,et al.  Determinants of the Host Range Restriction of Replication of Bovine Parainfluenza Virus Type 3 in Rhesus Monkeys Are Polygenic , 2003, Journal of Virology.

[39]  Brian R. Murphy,et al.  The Genome Length of Human Parainfluenza Virus Type 2 Follows the Rule of Six, and Recombinant Viruses Recovered from Non-Polyhexameric-Length Antigenomic cDNAs Contain a Biased Distribution of Correcting Mutations , 2003, Journal of Virology.

[40]  W. P. Duprex,et al.  Modulating the Function of the Measles Virus RNA-Dependent RNA Polymerase by Insertion of Green Fluorescent Protein into the Open Reading Frame , 2002, Journal of Virology.

[41]  V. ter meulen,et al.  Analysis of receptor (CD46, CD150) usage by measles virus. , 2002, The Journal of general virology.

[42]  B. Murphy,et al.  Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins. , 2002, Virology.

[43]  W. P. Duprex,et al.  Polyploid measles virus with hexameric genome length , 2002, The EMBO journal.

[44]  D. Garcin,et al.  All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. , 2002, Virology.

[45]  M. St. Claire,et al.  Mucosal Immunization of Rhesus Monkeys against Respiratory Syncytial Virus Subgroups A and B and Human Parainfluenza Virus Type 3 by Using a Live cDNA-Derived Vaccine Based on a Host Range-Attenuated Bovine Parainfluenza Virus Type 3 Vector Backbone , 2002, Journal of Virology.

[46]  M. Billeter,et al.  Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. , 2001, Virology.

[47]  David Montefiori,et al.  An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants , 2001, Cell.

[48]  K. Komase,et al.  Leucine at position 278 of the AIK-C measles virus vaccine strain fusion protein is responsible for reduced syncytium formation. , 2001, The Journal of general virology.

[49]  D. Garcin,et al.  Longer and Shorter Forms of Sendai Virus C Proteins Play Different Roles in Modulating the Cellular Antiviral Response , 2001, Journal of Virology.

[50]  Y. Yanagi,et al.  Morbilliviruses Use Signaling Lymphocyte Activation Molecules (CD150) as Cellular Receptors , 2001, Journal of Virology.

[51]  M. Billeter,et al.  Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses. , 2001, Vaccine.

[52]  M. Sidhu,et al.  Analysis of the Noncoding Regions of Measles Virus Strains in the Edmonston Vaccine Lineage , 2001, Journal of Virology.

[53]  M. Sidhu,et al.  Comparison of Predicted Amino Acid Sequences of Measles Virus Strains in the Edmonston Vaccine Lineage , 2001, Journal of Virology.

[54]  D. Garcin,et al.  Sendai Virus C Proteins Must Interact Directly with Cellular Components To Interfere with Interferon Action , 2000, Journal of Virology.

[55]  J. McAuliffe,et al.  Bovine Parainfluenza Virus Type 3 (BPIV3) Fusion and Hemagglutinin-Neuraminidase Glycoproteins Make an Important Contribution to the Restricted Replication of BPIV3 in Primates , 2000, Journal of Virology.

[56]  Y. Yanagi,et al.  SLAM (CDw150) is a cellular receptor for measles virus , 2000, Nature.

[57]  M. Billeter,et al.  Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells , 2000, The EMBO journal.

[58]  J. Johnson,et al.  Rescue of Mumps Virus from cDNA , 2000, Journal of virology.

[59]  B. Murphy,et al.  A Recombinant Human Parainfluenza Virus Type 3 (PIV3) in Which the Nucleocapsid N Protein Has Been Replaced by That of Bovine PIV3 Is Attenuated in Primates , 2000, Journal of Virology.

[60]  R. Pomerantz,et al.  Recombinant rabies virus as potential live-viral vaccines for HIV-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Stephen McQuaid,et al.  Observation of Measles Virus Cell-to-Cell Spread in Astrocytoma Cells by Using a Green Fluorescent Protein-Expressing Recombinant Virus , 1999, Journal of Virology.

[62]  Tokiko Watanabe,et al.  Generation of influenza A viruses entirely from cloned cDNAs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[63]  D. Garcin,et al.  Sendai Virus C Proteins Counteract the Interferon-Mediated Induction of an Antiviral State , 1999, Journal of Virology.

[64]  M. Billeter,et al.  The H Gene of Rodent Brain-Adapted Measles Virus Confers Neurovirulence to the Edmonston Vaccine Strain , 1999, Journal of Virology.

[65]  B. Peeters,et al.  Rescue of Newcastle Disease Virus from Cloned cDNA: Evidence that Cleavability of the Fusion Protein Is a Major Determinant for Virulence , 1999, Journal of Virology.

[66]  M. Billeter,et al.  A Recombinant Measles Virus Expressing Hepatitis B Virus Surface Antigen Induces Humoral Immune Responses in Genetically Modified Mice , 1999, Journal of Virology.

[67]  A. Roberts,et al.  Attenuated Vesicular Stomatitis Viruses as Vaccine Vectors , 1999, Journal of Virology.

[68]  T. Dubensky,et al.  Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[69]  M. Billeter,et al.  Nonstructural C Protein Is Required for Efficient Measles Virus Replication in Human Peripheral Blood Cells , 1999, Journal of Virology.

[70]  S. Finke,et al.  Generation of Bovine Respiratory Syncytial Virus (BRSV) from cDNA: BRSV NS2 Is Not Essential for Virus Replication in Tissue Culture, and the Human RSV Leader Region Acts as a Functional BRSV Genome Promoter , 1999, Journal of Virology.

[71]  M. Billeter,et al.  Recombinant Measles Viruses with Mutations in the C, V, or F Gene Have Altered Growth Phenotypes In Vivo , 1998, Journal of Virology.

[72]  A. Aguzzi,et al.  Measles Virus Spread and Pathogenesis in Genetically Modified Mice , 1998, Journal of Virology.

[73]  L. A. Ball,et al.  Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[74]  D. Garcin,et al.  Sendai viruses with altered P, V, and W protein expression. , 1998, Virology.

[75]  M. Billeter,et al.  Gudrun Envelope Chimeric Measles Viruses with a Foreign , 1997 .

[76]  R. Johnston,et al.  Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. , 1997, Virology.

[77]  P. Klenerman,et al.  A non-retroviral RNA virus persists in DNA form , 1997, Nature.

[78]  R. Lamb,et al.  Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. , 1997, Virology.

[79]  B. Murphy,et al.  Recovery of infectious human parainfluenza virus type 3 from cDNA. , 1997, Virology.

[80]  M. Hoffman,et al.  An infectious clone of human parainfluenza virus type 3 , 1997, Journal of virology.

[81]  T. Barrett,et al.  Rescue of rinderpest virus from cloned cDNA , 1997, Journal of virology.

[82]  M. Billeter,et al.  Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. , 1997, Virology.

[83]  Y. Nagai,et al.  Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense , 1996, Genes to cells : devoted to molecular & cellular mechanisms.

[84]  M. Billeter,et al.  The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. , 1996, Virology.

[85]  G. Atkins,et al.  Manipulation of the Semliki Forest virus genome and its potential for vaccine construction , 1996, Molecular biotechnology.

[86]  R. Chanock,et al.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[87]  M. Billeter,et al.  Rescue of measles viruses from cloned DNA. , 1995, The EMBO journal.

[88]  D. Garcin,et al.  A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy‐back nondefective interfering virus. , 1995, The EMBO journal.

[89]  S. Whelan,et al.  Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[90]  M. Whitt,et al.  Recombinant vesicular stomatitis viruses from DNA. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[91]  M. Billeter,et al.  Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene. , 1995, Virology.

[92]  R. Andino,et al.  Engineering poliovirus as a vaccine vector for the expression of diverse antigens. , 1994, Science.

[93]  K. Conzelmann,et al.  Infectious rabies viruses from cloned cDNA. , 1994, The EMBO journal.

[94]  M. Ryan,et al.  Foot‐and‐mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. , 1994, The EMBO journal.

[95]  K. Conzelmann,et al.  Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins , 1994, Journal of virology.

[96]  L. Roux,et al.  The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA , 1993, Journal of virology.

[97]  P. Collins,et al.  Rescue of a 7502-nucleotide (49.3% of full-length) synthetic analog of respiratory syncytial virus genomic RNA. , 1993, Virology.

[98]  P. Collins,et al.  Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[99]  M. Billeter,et al.  Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm. , 1991, Virology.

[100]  F. F. Correia,et al.  Rescue of a foreign gene by Sendai virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[101]  P. Palese,et al.  Introduction of site-specific mutations into the genome of influenza virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[102]  A. Sugiura,et al.  Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus , 1990, Journal of virology.

[103]  J. Parvin,et al.  Amplification, expression, and packaging of a foreign gene by influenza virus , 1989, Cell.

[104]  M. Billeter,et al.  Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. , 1989, Virology.

[105]  M. Billeter,et al.  Measles virus editing provides an additional cysteine-rich protein , 1989, Cell.

[106]  M. Billeter,et al.  Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA , 1989, Cell.

[107]  Roberto Cattaneo,et al.  Biased hypermutation and other genetic changes in defective measles viruses in human brain infections , 1988, Cell.

[108]  D. Baltimore,et al.  Cloned poliovirus complementary DNA is infectious in mammalian cells. , 1981, Science.

[109]  T. Taniguchi,et al.  Qβ DNA-containing hybrid plasmids giving rise to Qβ phage formation in the bacterial host , 1978, Nature.

[110]  Charles Weissmann,et al.  Nucleotide sequence heterogeneity of an RNA phage population , 1978, Cell.

[111]  A. Barr.  REALLOCATION OF RESOURCES , 1976, The Lancet.

[112]  A. Bluming,et al.  Regression of Burkitt's lymphoma in association with measles infection. , 1971, Lancet.

[113]  K. Ljungberg,et al.  Vaccine delivery methods using viral vectors. , 2007, Molecular pharmaceutics.

[114]  Fred Mitchell,et al.  Replication of chimeric yellow fever virus-dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells. , 2005, The American journal of tropical medicine and hygiene.

[115]  R. Cattaneo,et al.  Toward novel vaccines and therapies based on negative-strand RNA viruses. , 2004, Current topics in microbiology and immunology.

[116]  A. Jiménez-Corona,et al.  Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. , 2002, Bulletin of the World Health Organization.

[117]  M. Billeter,et al.  A recombinant measles virus expressing biologically active human interleukin-12. , 1999, The Journal of general virology.

[118]  A. Roberts,et al.  Redesign and genetic dissection of the rhabdoviruses. , 1999, Advances in virus research.

[119]  I. Tubulekas,et al.  Alphavirus expression vectors and their use as recombinant vaccines: a minireview. , 1997, Gene.

[120]  A. Lamb.  Paramyxoviridae : The virus and their replication , 1996 .

[121]  R. Lamb,et al.  Orthomyxoviridae: The Viruses and Their Replication. , 1996 .

[122]  M. Billeter,et al.  Mutations and A/I hypermutations in measles virus persistent infections. , 1992, Current topics in microbiology and immunology.